文献速递疼痛医学神经外科与老年麻醉

ROR2通过磷酸化GluN2B调节大鼠神经病理性疼痛

ROR2 modulates neuropathic pain via phosphorylation of NMDA receptor subunit GluN2B in rats.
PubMed 文献 · Br J Anaesth · 2018-10-29

该研究在大鼠慢性坐骨神经压迫模型中发现,脊髓神经元ROR2在造模后第1-21天上调并激活,启动子CpG岛去甲基化;敲低ROR2可预防和逆转痛行为及神经元敏化,而鞘内注射Wnt5a激活ROR2则诱导痛行为,该调节依赖PKC和Src家族激酶对GluN2B Ser1303和Tyr1472的磷酸化。

要点

  • 脊髓ROR2在CCI后上调并激活,参与神经病理性疼痛维持
  • 敲低ROR2可预防和逆转CCI诱导的痛行为及神经元敏化
  • ROR2通过PKC/Src磷酸化GluN2B Ser1303和Tyr1472调控疼痛

核心结论

  • 脊髓ROR2通过磷酸化GluN2B调节神经病理性疼痛,可能是预防和缓解神经病理性疼痛的潜在靶点。

研究设计与样本

  • 研究采用小鼠慢性坐骨神经压迫(CCI)神经病理性疼痛模型,通过热辐射和von Frey纤维测试评估热痛敏和机械性痛敏。

主要发现

  • CCI后第1-21天脊髓神经元ROR2表达上调并激活,为假手术组的1.3(0.1)至2.1(0.1)倍,P<0.01。
  • CCI诱导ROR2基因启动子CpG岛显著去甲基化,CpG甲基化水平为0.37(0.06)% vs 0.12(0.03)%,P<0.001。
  • 敲低脊髓ROR2可预防和逆转CCI诱导的痛行为及脊髓神经元敏化,Fos表达为130(12)vs 81(8)个细胞和120(11)vs 70(7)个细胞,均P<0.05。
  • 鞘内注射Wnt5a激活脊髓ROR2可在野生型小鼠诱导痛行为和脊髓神经元敏化,Fos表达为11(1)vs 100(12)个细胞,P<0.001。
  • ROR2介导的疼痛调节需要PKC和Src家族激酶途径磷酸化GluN2B的Ser1303和Tyr1472;鞘内注射GluN2B、PKC或Src家族激酶特异性抑制剂可显著减轻Wnt5a诱导的痛行为。

临床怎么用

  • 脊髓ROR2及其下游GluN2B磷酸化位点可能作为神经病理性疼痛预防和治疗的潜在靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Neuropathic pain, a type of chronic pain as a result of direct central or peripheral nerve damage, is associated with significant quality of life and functional impairment. Its underlying mechanisms remain unclear. We investigated whether ROR2, a member of the receptor tyrosine kinase-like orphan receptor (ROR) family, participates in modulation of neuropathic pain. METHODS: Thermal hyperalgesia and mechanical allodynia were measured using radiant heat and von Frey filament testing. Immunofluorescence staining was used to detect expression of ROR2 in neuronal nuclei. Fos expression was determined by immunocytochemistry. Phosphorylation status was detected by western blot and immunoprecipitation. Small interfering RNA was used to knock down ROR2 expression. RESULTS: ROR2 was upregulated and activated in spinal neurones after chronic constriction injury (CCI) in mice [1.3 (0.1) to 2.1 (0.1)-fold of sham, P<0.01] from Day 1-21. CCI induced significant demethylation of the CpG island in the ROR2 gene promoter [0.37 (0.06) vs 0.12 (0.03)% CpG methylation, P<0.001]. Knockdown of ROR2 in the spinal cord prevented and reversed CCI-induced pain behaviours and spinal neuronal sensitisation [Fos expression: 130 (12) vs 81 (8) cells, P<0.05; 120 (11) vs 70 (7) cells, P<0.05]. In contrast, activation of spinal ROR2 by intrathecal injection of Wnt5a induced pain behaviours and spinal neuronal sensitisation [Fos expression: 11 (1) vs 100 (12) cells, P<0.001] in wild-type mice. Furthermore, ROR2-mediated pain modulation required phosphorylation of N-methyl-D-aspartate receptor 2B subunit (GluN2B) at Ser 1303 and Tyr1472 by pathways involving protein kinase C (PKC) and Src family kinases. Intrathecal injection of GluN2B, PKC, or Src family kinase-specific inhibitors significantly attenuated Wnt5a-induced pain behaviours. CONCLUSIONS: ROR2 in the spinal cord regulates neuropathic pain via phosphorylation of GluN2B, suggesting a potential target for prevention and relief of neuropathic pain.

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Zhou XL, Zhang CJ, Peng YN, et al. ROR2 modulates neuropathic pain via phosphorylation of NMDA receptor subunit GluN2B in rats. Br J Anaesth. 2018. PMID: 30916039. doi:10.1016/j.bja.2018.08.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。